Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 16, 2026
Ferrari (RACE) Eyes the $500 Level: What It Would Take to Reclaim That Milestone

Ferrari (RACE) Eyes the $500 Level: What It Would Take to Reclaim That Milestone

Key Takeaways

  • Price target in focus: $500 per share — a psychologically significant round number roughly 33% above Ferrari's recent closing price near $375 and just below the stock's 52-week high of $519.10.
  • Strongest bullish factors: Record order backlogs extending into 2027, industry-leading EBITDA margins approaching 39%, disciplined scarcity-driven production, and successful hybrid model adoption now representing over 60% of deliveries.
  • Key risks: Elevated valuation with a trailing P/E ratio above 36x, potential luxury spending slowdown amid macroeconomic uncertainty, U.S. import tariff exposure, and execution risk around the first full-electric Ferrari launch.
  • Technical levels to watch: The 200-day simple moving average near $352 serves as current support, while the $420–$440 range represents the next major resistance zone, with $500 standing as both a psychological and structural upside objective.
  • Bottom line for investors: A return to $500 appears achievable but likely requires a multi-quarter catalyst — whether a successful EV debut, sustained earnings beats, or renewed luxury demand tailwinds — rather than a rapid technical breakout.

The $500 Threshold and Why It Matters Now

Ferrari N.V. (RACE) reached an all-time high of $519.10 on July 25, 2025, then pulled back sharply, touching a 52-week low of $312.51 in March 2026. From that low, the stock has recovered above $375, and the $500 mark has become a focal point for many investors tracking the recovery. Reclaiming it would mark a full retracement of the post-peak decline.

Analyst views align with that possibility. MarketBeat data shows 18 analysts maintaining a consensus "Moderate Buy" rating and an average 12-month price target of $471.97. The highest target stands at $570, while UBS raised its target to $497 and Morgan Stanley upgraded to "Overweight" with a $438 target in June 2026. These forecasts position $500 as an ambitious yet plausible objective within the range.

Ferrari's Business Strength and Market Standing

Ferrari holds a distinctive place in the automotive sector. The company delivered 13,640 vehicles in 2025 at an average price above €500,000, producing roughly €7.15 billion in revenue, up 7% year-over-year. Guidance points to about €7.5 billion in 2026 revenue with EBITDA margins near 39%, levels that remain among the strongest in the industry.

The order book stretches well into 2027, with typical wait times of 18 to 24 months. This stems from a long-standing approach of limiting supply to maintain exclusivity. Roughly 84% of revenue comes from cars and spare parts, with the balance from sponsorships, commercial activities, licensing, and lifestyle products. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Potential Drivers Toward $500

Several factors could support further gains for RACE. The upcoming launch of the first fully electric Ferrari, priced above $500,000, stands out as a key event. A smooth introduction could reinforce the company's electrification plans and attract additional investor interest.

Personalization options continue to lift average selling prices as buyers select custom features. The limited-edition F80 hypercar, priced at $3.8 million with only 799 units and all already allocated, should contribute to 2026 results as deliveries occur. Formula One sponsorship income and brand licensing add more stable revenue streams that help buffer against broader economic shifts.

Headwinds and Valuation Concerns

Valuation remains a notable consideration. At roughly 36x trailing earnings and over 8x sales, Ferrari trades at a premium to most automotive peers. Any shortfall in execution, especially with the electric vehicle rollout, could lead to multiple contraction. Jefferies reduced its target to €310 in late 2025, citing ramp-up costs and higher depreciation.

U.S. tariffs on EU vehicles pose another risk, with management estimating roughly 50 basis points of margin pressure, or about €35 million. While pricing power has historically allowed cost pass-through, prolonged tariffs could test that flexibility. Luxury spending sensitivity to interest rates and wealth effects also warrants attention.

Key Technical Levels to Monitor

From a technical standpoint, RACE trades above its 50-day simple moving average near $354 and 200-day simple moving average near $352, indicating a constructive intermediate trend. The $420 area forms the next resistance zone, having acted as both support and resistance in prior moves. A sustained move above $420–$440 could open the way toward $480–$500.

On the downside, the $350 region, supported by the moving averages, offers initial protection. A drop below the March 2026 low of $312 would challenge the recovery setup and shift attention lower.

Analyst Views and Institutional Flows

Sentiment among analysts remains positive. Of the 18 tracked by MarketBeat, 13 rate the stock "Buy" or "Strong Buy," five rate it "Hold," and none recommend "Sell." JPMorgan raised its target to $447 in March 2026 while keeping an "Overweight" rating, and UBS lifted its target to $497 in July 2026. Institutional interest has also increased, with Bank of New York Mellon growing its position by 8.4% in the first quarter of 2026 to around $950 million.

The average target near $472 implies about 26% upside from recent levels, placing $500 as a reasonable extension beyond the consensus but within the upper end of forecasts.

Using AI Tools for Ongoing Monitoring

Traders looking for a structured approach to track RACE price action may find value in Tickeron's AI Daily Buy/Sell Signals. This tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals derived from technical patterns and market conditions. It offers a way to stay updated on potential shifts without reviewing every indicator manually. In my routine research, I have found these signals helpful for highlighting emerging trends or changes in momentum.

Overall Outlook

Reaching $500 for Ferrari shares looks plausible but would likely unfold over multiple quarters rather than in a quick move. The company's strong brand position, controlled production, extended order visibility, and high margins create a solid base. Analyst targets and institutional buying reflect confidence in the recovery story.

The route forward will probably include volatility. High valuation leaves limited margin for disappointment, the economic backdrop carries uncertainty, and the electric vehicle shift brings its own execution considerations. Watching quarterly deliveries, margin trends, EV progress, and the stock's position relative to moving averages will be useful. A sustained break above $420–$440 would strengthen the case for $500, while any loss of the $350 support area would call for greater caution.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RACE

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for RACE turns positive, indicating new upward trend

RACE saw its Momentum Indicator move above the 0 level on July 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RACE just turned positive on July 29, 2026. Looking at past instances where RACE's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for RACE moved above the 200-day moving average on July 31, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RACE advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 263 cases where RACE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RACE moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RACE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RACE broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RACE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.978) is normal, around the industry mean (9.096). P/E Ratio (38.067) is within average values for comparable stocks, (542.026). Projected Growth (PEG Ratio) (4.072) is also within normal values, averaging (2.773). Dividend Yield (0.010) settles around the average of (0.038) among similar stocks. P/S Ratio (8.446) is also within normal values, averaging (11.068).

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 61.15B. The market cap for tickers in the group ranges from 3.72K to 1.27T. TSLA holds the highest valuation in this group at 1.27T. The lowest valued company is ZAPPF at 3.72K.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -3%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -22%. SEV experienced the highest price growth at 19%, while LVWR experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 58
Price Growth Rating: 64
SMR Rating: 93
Profit Risk Rating: 92
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
RACE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of an automobile company, which engages in the designing, engineering, producing and selling of sports cars

Industry MotorVehicles

Profile
Details
Industry
Motor Vehicles
Address
Via Abetone Inferiore n. 4
Phone
+39 536949111
Employees
4988
Web
https://www.ferrari.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.